| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.3B | $2.4B | $2.2B | $2.3B | $2.1B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $0.5B | $0.0B | $0.1B | $0.2B | $0.2B | $0.0B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $1.6B | $1.3B | $1.5B | $0.3B | $1.4B | $1.6B |
| Net Income | $0.8B | $0.9B | $1.1B | $0.0B | $0.6B | $1.0B |
| EPS (Basic) | $1.79 | $1.92 | $2.54 | $0.10 | $1.49 | $1.32 |
| EPS (Diluted) | $1.78 | $1.91 | $2.53 | $0.10 | $1.49 | $1.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $19.6B | $18.2B | $16.4B | $16.8B | $17.5B | $16.0B |
| Current Assets | $1.5B | $1.8B | $1.3B | $2.6B | $2.9B | $2.7B |
| Cash & Equivalents | $0.6B | $0.9B | $0.5B | $1.7B | $1.5B | $1.0B |
| Total Liabilities | $9.9B | $7.9B | $6.3B | $7.3B | $7.3B | $6.1B |
| Current Liabilities | $0.6B | $1.3B | $0.2B | $1.2B | $0.2B | $0.3B |
| Stockholders' Equity | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.8B | $3.0B | $2.1B | $2.0B | $2.0B |
| Investing Cash Flow | $-1.6B | $-2.7B | $-2.1B | $-1.0B | $-1.9B | $-2.8B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-1.2B | $0.4B | $-2.1B | $-0.9B | $0.4B | $1.5B |